Subcon Manufacturing Corporation - Close Out Letter 5/5/14
- Subcon Manufacturing Corporation
Department of Health and Human Services
|Food and Drug Administration|
550 West Jackson Blvd., 15th Floor
Chicago, Illinois 60661
May 5, 2014
Mr. Charles T. Walneck
President and Chief Executive Officer
Subcon Manufacturing Corporation
201 Berg Street
Algonquin, IL 60101
Dear Mr. Walneck:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter, CHI-1-14, dated December 16, 2013. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Scott J. MacIntire